Civetta Therapeutics

Civetta Therapeutics was established with the aim of advancing novel medications by targeting beta-propeller domains using small molecules, with the objective of creating significant treatments for various diseases including cancer. Propeller proteins serve as architectural frameworks that facilitate distinct substrate protein interactions. These proteins are present widely in different cell types and can play various functional roles in the development of cancer, neurodegenerative diseases, metabolic disorders, and other areas.